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Tight blood pressure control decreases apoptosis during renal
damage.
Background. An excess rate of apoptosis could lead to the
gradual loss of renal mass. In this study, we investigated the role
of apoptosis in the renal damage secondary to hypertension.
Methods. Spontaneously hypertensive rats with 5/6 renal
mass reduction (subtotal nephrectomy) were distributed to re-
ceive no-treatment, 200 mg/L quinapril, 360 mg/L losartan, or
triple therapy (200 mg/L hydralazine, 4 mg/L reserpine, and
100 mg/L hydrochlorothiazide) for 5 weeks. Sham-operated
spontaneously hypertensive rats served as controls. Age-
matched Wistar-Kyoto (WKY) rats, with or without subtotal
nephrectomy, were also studied.
Results. Nontreated spontaneously hypertensive rats +
subtotal nephrectomy developed proteinuria, glomerular
sclerosis, and tubulointerstitial lesions. In comparison to spon-
taneously hypertensive rats, an increment in the number of
[proliferating cell nuclear antigen (PCNA)]-positive and apop-
totic [terminal deoxynucleotidyl transferase (Tdt)-mediated
deoxyuridine triphosphate biotin nick end labeling (TUNEL)]-
positive tubular and glomerular cells was observed. By con-
trast, WKY + subtotal nephrectomy rats showed less severe
morphologic lesions, and only the number of proliferating cells
increased. By Western blot, an up-regulation of renal Bax
(apoptosis inducer) was noted both in spontaneously hyper-
tensive rats + subtotal nephrectomy and WKY + subtotal
nephrectomy rats. By contrast, Bcl-xL (apoptosis protector) was
up-regulated in WKY + subtotal nephrectomy rats but not in
spontaneously hypertensive rats + subtotal nephrectomy. The
administration of appropriate doses of quinapril, losartan, or
triple therapy to spontaneously hypertensive rats + subtotal
nephrectomy normalized systolic blood pressure, partially pre-
vented proteinuria, renal lesions and apoptosis, and decreased
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Bax, but no changes were noted in Bcl-xL. The Bax/Bcl-xL in-
dex was significantly increased in spontaneously hypertensive
rats + subtotal nephrectomy compared to sham-operated spon-
taneously hypertensive rats and decreased in treated groups.
Conclusion. The combination of renal mass reduction and
hypertension caused severe renal lesions associated to an in-
crement of apoptosis rate, mainly in tubular epithelial cells.
Tight blood pressure control decreased the apoptosis rate and
morphologic lesions. These studies suggest that changes in the
expression of apoptosis-regulatory genes contribute to the pro-
gressive damage in hypertensive rats with renal mass reduction.
Arterial hypertension is a leading cause of end-stage
renal disease (ESRD); but also an important factor in
the progression of other forms of chronic renal disease
[1, 2]. Although the histologic manifestations of hyper-
tensive nephrosclerosis are well known (glomerular and
arterioarteriolar sclerosis associated with inflammatory
cell infiltration, interstitial fibrosis, and tubular atrophy)
[3], the pathophysiologic process that results in pro-
gressive renal failure secondary to hypertension remains
unresolved.
Apoptosis, or programmed cell death, is a gene-
regulated process that is now recognized to play an im-
portant role in maintaining cell number homeostasis both
in health and disease (reviewed in [4, 5]). Cell deletion
by apoptosis has been implicated in the repairing pro-
cess of several renal diseases. In addition, unregulated
excessive apoptosis can contribute to progressive chronic
nephropathies, including hypertensive nephrosclerosis,
by depletion of glomerular and tubular cells [4–6]. How-
ever, data on the response of renal cell apoptosis to
adequate blood pressure control are scarce, and the
molecular mechanisms are poorly understood.
Apoptosis is controlled in part by the Bcl-2 family of
regulatory proteins (Bcl-2, Bcl-x, Bax, and others). Bcl-2
can prevent or delay many forms of apoptosis [7]. Bcl-x
has two alternatively spliced forms: Bcl-xL that protects
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cells from a wide variety of apoptotic stimuli; and Bcl-xS
that has opposing effects to Bcl-2 and Bcl-xL [5, 7]. Bax
binds to and antagonizes the protective effect of Bcl-2 and
Bcl-xL [8]. In this sense, the ratio of expression of Bcl-2
or Bcl-xL to Bax or Bcl-xS appears to determine cell sus-
ceptibility to apoptosis when the microenvironment is ad-
verse for survival. In adult organs, including the kidney,
the levels of Bcl-xL appear higher than those of Bcl-2 [9].
The present study was designed to investigate the
role of apoptosis in the progressive renal damage as-
sociated to hypertension and whether the expression of
apoptosis-related genes was altered in these animals. In
order to assess this hypothesis, we have employed spon-
taneously hypertensive rats, an experimental model con-
sidered to be similar in many aspects to hypertension in
humans. Spontaneously hypertensive rats with intact re-
nal mass have normal renal autoregulation, and develop
systemic hypertension and vascular and renal injury over
the years. However, subtotal nephrectomy leads to an
increment in the glomerular capillary pressure and ac-
celerates glomerulosclerosis in a pattern similar to that
observed in malignant hypertension [10]. In addition, we
have studied apoptosis in response to the tight blood pres-
sure control with three antihypertensive therapy regimes
[i.e., angiotensin-converting enzyme (ACE) inhibition,
angiotensin II receptor antagonism, and triple therapy].
METHODS
Experimental model
Studies were performed in 8-week-old male sponta-
neously hypertensive rats (Criffa, Barcelona, Spain). All
rats had free access to standard rat chow and water.
Animals underwent subtotal nephrectomy as a two-step
procedure: ligation of two or three branches of the left
renal artery, followed, 7 days later, by total right nephrec-
tomy. Just after the right nephrectomy, spontaneously
hypertensive rats were randomly distributed into dif-
ferent groups: (1) nontreated group (spontaneously hy-
pertensive rats + subtotal nephrectomy), animals with
spontaneous development of the disease (N = 7); (2)
quinapril group (quinapril + spontaneously hypertensive
rats + subtotal nephrectomy), animals that received 200
mg/L quinapril (as powdered hydrochloride salt) (Pfizer,
Madrid, Spain) in the drinking water (N = 7); (3) losar-
tan group (losartan + spontaneously hypertensive rats +
subtotal nephrectomy), animals receiving 360 mg/L losar-
tan (Merck Sharp & Dohme, Madrid, Spain) in the drink-
ing water (N = 8); and (4) triple-therapy group (triple
therapy + spontaneously hypertensive rats + subtotal
nephrectomy), animals receiving 200 mg/L hydralazine,
4 mg/L reserpine, and 100 mg/L hydrochlorothiazide in
the drinking water (N = 5).
A pilot study of 2-week duration was performed in or-
der to obtain the dose of losartan, quinapril, and triple
therapy (hydralazine, reserpine, and hydrochloroth-
iazide) that decreases and maintains systolic blood pres-
sure within normal range.
At the same time, a group of spontaneously hyper-
tensive rats underwent a sham operation (N = 6) and
served as controls. Two further groups of age-matched
normotensive Wistar-Kyoto (WKY) rats, with or without
subtotal nephrectomy (N = 4 and 5, respectively), were
also studied.
After 5 weeks of study, at 14 weeks of age, all rats
were anesthetized with pentobarbital sodium (5 mg/100 g
body weight) and kidneys were perfused with cold sodium
saline and removed.
Measurement of systolic blood pressure
and renal function
Systolic blood pressure was measured weekly in
conscious animals by a tail-cuff sphygmomanometer
(NARCO Biosystems, Austin, TX, USA). Periodically,
animals were maintained in metabolic boxes during
24 hours in order to collect the urine. Total urinary
protein excretion was quantified by the method of the
sulfosalicylic acid [11]. Renal function (measured as cre-
atinine clearance) was calculated from a urine sample
taken 24 hours before the animal sacrifice.
Renal histopathologic studies
For light microscopy, paraffin-embedded renal sec-
tions (4 lm thick) were prepared and stained with
hematoxylin-eosin and Masson’s trichrome. For each an-
imal, the percentage of glomeruli exhibiting global or
segmental sclerosis was determined. Sclerosis was evi-
denced by an increase in mesangial matrix and/or collapse
and condensation of the glomerular basement membrane
[12]. Tubulointerstitial injury (defined as tubular dilation
and/or atrophy, interstitial fibrosis and inflammatory cell
infiltrate) were graded by the following semiquantitative
score [13]: 0, no changes; 1, focal changes that involve
25% of the sample; 2, changes affecting >25% to 50% of
the sample; 3, changes involving >50% to 75%; 4, lesions
affecting >75% of the sample. In all cases, renal biopsies
were only taken from the center of the noninfarcted area.
All these studies were performed in a blinded fashion by
two observers.
Immunohistochemistry
Immunolocalization of proliferating cell nuclear anti-
gen (PCNA) and apoptosis-related proteins Bax and
Bcl-xL was performed in paraffin-embedded renal tis-
sues. Briefly, 4 lm thick sections were dewaxed and rehy-
drated by descending ethanol concentrations. For PCNA
detection, sections were also treated by oven heating
in 0.01 mol/L sodium citrate, pH 6.0, for 10 minutes.
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After the quenching of endogenous peroxidase activity,
sections were incubated with a prediluted monoclonal
mouse antirat PCNA (PC-10) (Zymed Laboratories,
Inc., San Francisco, CA, USA), a rabbit polyclonal anti-
mouse/rat Bax antibody (BD Bioscience, Madrid, Spain)
diluted 7 lL/mL or a rabbit polyclonal antihuman Bcl-
xS/L antibody (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA.) diluted 1:50 overnight at 4◦C in a
humid atmosphere. Thereafter, sections were processed
using avidin-biotin immunoperoxidase method [AB-
Complex/horseradish peroxidase (HRP)] (Dako A/S,
Glostrup, Denmark) with 3-3′-diamino-benzidine (DAB)
(Sigma, Madrid, Spain) as the chromogen. The tis-
sue sections were counterstained with Mayer’s hema-
toxylin (Sigma). Negative controls were performed in
parallel for specific labelings by replacing the primary
antibody with a nonimmune normal rabbit serum.
PCNA-positive cells were quantified by image analysis
as described below. Bax and Bcl-xS/L immunostaining
results were evaluated by two independent observers in
a blinded fashion.
In situ detection of apoptosis
Apoptosis was detected by terminal deoxynucleotidyl
transferase (TdT)-mediated deoxyuridine triphosphate
(dUTP)-biotin nick end labeling (TUNEL) using a com-
mercial kit (FragElTM DNA Fragmentation Detection
Kit) (Oncogene Research Products, Cambridge, MA,
USA). Briefly, after deparaffinization and rehydration,
renal sections (4 lm thick) were treated with 20 lg/mL
proteinase K and immersed in 3% H2O2 in methanol for
10 minutes. Slides were rinsed with Tris-buffered saline
(TBS), immersed in TdT equilibration buffer, and then
incubated with TdT and biotinylated-dUTP at 37◦C for
2 hours. For negative controls, sections were incubated in
TdT buffer without TdT. The reactions were stopped with
0.5 mol/L ethylenediaminetetraacetic acid (EDTA), pH
8. Biotinylated-dUTP-labeled DNA was detected and vi-
sualized using a streptavidin-HRP conjugated and DAB
(Sigma) as the chromogen. Tissue sections were coun-
terstained with Mayer’s hematoxylin (Sigma) or methyl
green.
Counts of proliferating (PCNA-positive)
and apoptotic (TUNEL-positive) cells
The number of cells positive to PCNA and TUNEL
were quantified in a blinded fashion with computer-
assisted image analysis software (Optimas 6.5) (Media
Cybernetics, Silver Spring, MD, USA) and digitized im-
ages. For each renal cortex section, proliferating glomeru-
lar cells were calculated by counting at least 20 glomeruli
per biopsy and expressed as the mean number ± SEM
per glomeruli. In tubulointerstitium, proliferating cells
were calculated by counting all positive PCNA cells in
four to six not overlapping random fields viewed at
×200 magnification (excluding glomeruli) and expressed
as the mean number ± SEM per field. Only intense
brown/black-stained nuclei were considered as PCNA-
positive staining. The corresponding number of cells un-
dergoing apoptosis was calculated in the same manner.
Only intense brown/black-stained nuclei, including py-
knotic nuclei with apoptotic bodies that stained positive,
were considered as TUNEL-positive staining.
Western blot
Tissue samples were homogenized in lysis buffer
[50 mmol/L TrisHCl, 150 mmol/L NaCl, 2 mmol/L EDTA,
2 mmol/L ethylene glycol tetraacetate (EGTA), 0.2%
Triton X-100, 0.3% NP-40, 0.1 mmol/L phenylmethyl-
sulfonyl fluoride (PMSF), and 1 lg/mL pepstatin A]
and then separated by 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) under
reducing conditions. After electrophoresis, samples were
transferred to polyvinyldene difluoride (PVDF) mem-
branes (Millipore Corp., Bedford, MA, USA), blocked
with 5% bovine serum albumin (BSA) in phosphate-
buffered saline (PBS)/0.5% Tween-20 (vol/vol) for
1 hour, washed with PBS/Tween-20, and incubated with
the following antibodies: rabbit polyclonal antimouse
Bax antibody (1:500) (Santa Cruz Biotechnology, Inc.)
and rabbit polyclonal antihuman Bcl-xS/L (1:500) (Santa
Cruz Biotechnology, Inc.). Although the anti-Bcl-x anti-
body employed recognized both S and L forms, only a
unique band corresponding to the L form was observed
in all groups of rats (Fig. 5). Blots were washed with
PBS/Tween-20 and subsequently incubated with HRP-
conjugated antirabbit IgG (1:2000) (Amersham, Ayles-
bury, UK). After washing with PBS/Tween-20 the blots
were developed with the chemiluminescence method
(ECL) (Amersham).
Statistical analysis
Results are expressed as mean ± SEM. Data from mul-
tiple groups were compared using the unpaired Student
t test or the Kruskal-Wallis nonparametric analysis of
variance (ANOVA) test when appropriate. Differences
were considered significant if the P value was less than
0.05.
RESULTS
Evolution of the systolic blood pressure and proteinuria
Severe hypertension was already present in 8-week-
old spontaneously hypertensive rats at the beginning of
the study (187 ± 3 vs. WKY, 108 ± 6 mm Hg) (N = 10
to 28 per group, P < 0.05). Immediately after the right
nephrectomy, spontaneously hypertensive rats were ran-
domized into five groups: (1) spontaneously hypertensive
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Table 1. Proteinuria in normotensive Wistar-Kyoto (WKY) rats and
spontaneously hypertensive rats (SHR) with and without subtotal
nephrectomy (SNx) at baseline and at end of the follow-up period.
Some SHR with SNx received quinapril (Q) (200 mg/L), losartan (L)
(360 mg/L), or triple therapy (TT) (200 mg/L hydralazine, 4 mg/L
reserpine, 100 mg/L hydrochlorothiazide) in the drinking water for
5 weeks
Proteinuria mg/24 hours
Basal values After 5 weeks of study
WKY (N = 4) 9 ± 2 8 ± 1
WKY + SNx (N = 5) 9 ± 1 13 ± 2a,c
SHR (N = 6) 15 ± 2 21 ± 1a
SHR + SNx (N = 7) 18 ± 1 47 ± 7a,b
Q + SHR + SNx (N = 7) 20 ± 1 24 ± 4a,c
L + SHR + SNx (N = 8) 25 ± 3 23 ± 1a,c
TT + SHR + SNx (N = 5) 18 ± 1 22 ± 3a,c
Data represent mean ± SEM.
aP < 0.05 vs. WKY at the same age.
bP < 0.05 vs. SHR at the same age.
cP < 0.05 vs. SHR + SNx at the same age.
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Fig. 1. Serial values of systolic blood pressure during the 5-week pe-
riod of study in normal Wistar-Kyoto (WKY) rats, WKY with subtotal
nephrectomy (SNx), spontaneously hypertensive rats (SHR), SHR +
SNx, quinapril(Q)-treated SHR + SNx, losartan (L)-treated SHR +
SNx, and triple therapy(TT)-treated SHR + SNx. Data represent mean
± SEM, N = 4 to 8 animals per group. ∗P < 0.05 with respect to WKY;
#P < 0.05 with respect to SHR + SNx without treatment.
rats + subtotal nephrectomy; (2) quinapril + sponta-
neously hypertensive rats + subtotal nephrectomy; (3)
losartan + spontaneously hypertensive rats + subtotal
nephrectomy; (4) triple therapy + spontaneously hy-
pertensive rats + subtotal nephrectomy; and (5) sham-
operated spontaneously hypertensive rats animals. At
this time, neither the proteinuria nor the systolic blood
pressure differed between spontaneously hypertensive
rats from the different groups (Table 1) (Fig. 1). By con-
trast, at the end of the study, spontaneously hypertensive
rats + subtotal nephrectomy showed significantly higher
urinary protein excretion and systolic blood pressure than
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Fig. 2. Renal function at the end of the 5-week period of study in
spontaneously hypertensive rats (SHR), SHR + subtotal nephrectomy
(SNx), quinapril (Q)-treated SHR + SNx, losartan (L)-treated SHR
+ SNx, and triple therapy (TT)-treated SHR + SNx. Data represent
mean ± SEM, N = 5 to 8 animals per group. ∗P < 0.01 with respect to
SHR + SNx; #P < 0.01 with respect to SHR + SNx without treatment.
sham-operated spontaneously hypertensive rats (Table 1)
(Fig. 1). The reduction of renal mass in WKY rats also in-
creased proteinuria and systolic blood pressure, although
without reaching spontaneously hypertensive rats values
(Table 1) (Fig. 1).
The administration of quinapril (200 mg/L), losartan
(360 mg/L), and triple therapy (200 mg/L hydralazine,
4 mg/L reserpine, 100 mg/L hydrochlorothiazide) to spon-
taneously hypertensive rats + subtotal nephrectomy de-
creased significantly systolic blood pressure after 1 week
of treatment (Fig. 1). After 2 weeks, all treatments ad-
equately controlled systolic blood pressure, which re-
mained at normotensive range throughout the rest of the
study period (Fig. 1). Treatment with quinapril, losartan,
or triple therapy prevented the appearance of severe pro-
teinuria (table 1), and resulted in significantly preserved
renal function (Fig. 2).
Study of the histologic lesions
At the end of the study, normotensive sham-operated
animals did not show evidence of renal lesion. Hyperten-
sive sham-operated animals showed occasional sclerotic
glomeruli and some inflammatory cells. Both in nor-
motensive and hypertensive animals, subtotal nephrec-
tomy induced a significant increment in the number of
sclerotic glomeruli, as well as marked tubulointersti-
tial damage (tubular atrophy, interstitial inflammatory
cells, and fibrosis) with respect to sham-operated control
groups (Fig. 3). Morphologic lesions displayed by sponta-
neously hypertensive rats + subtotal nephrectomy were
more severe than those in WKY + subtotal nephrectomy.
The administration of quinapril, losartan, or triple
therapy to spontaneously hypertensive rats + subtotal
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Fig. 3. Renal tissue from normal Wistar-
Kyoto (WKY) rats (A), WKY + subtotal
nephrectomy (SNx) (B), spontaneously hy-
pertensive rats (SHR) (C), SHR + SNx (D),
quinapril (Q)-treated SHR + SNx (E), losar-
tan (L)-treated SHR + SNx (F), and triple
therapy (TT)-treated SHR + SNx (G). SHR
(C) did not show important renal morphologic
lesions. By contrast, WKY + SNx (B) and
SHR + SNx (D) presented marked glomeru-
lar and tubulointerstitial damage, being the le-
sions more severe in SHR + SNx than in WKY
+ SNx. The administration of quinapril, losar-
tan, or triple therapy to SHR + SNx improved
significantly renal damage (E, F and G, re-
spectively), compared to SHR + SNx without
treatment (magnification ×10). Percentage
(%) of sclerotic glomeruli (H) and histologic
tubulointerstitial damage score (I) of all stud-
ied groups. Data represent mean ± SEM,
N = 4 to 8 animals per group. ∗P < 0.05 with
respect to WKY + SNx; #P < 0.05 with respect
to SHR + SNx without treatment.
nephrectomy ameliorated renal damage, although mor-
phologic lesions were not completely normalized in any
group (Fig. 3).
Localization of cell proliferation in renal tissue
At the end of the study, sham-operated spontaneously
hypertensive rats showed higher number of PCNA-
positive cells, mainly in the interstitial and tubular com-
partments, than WKY rats (Fig. 4), coinciding with
previous studies that demonstrate that cells from genet-
ically hypertensive rats proliferate at a higher rate than
those of normotensive origin [14]. Both spontaneously
hypertensive rats and WKY with subtotal nephrectomy
showed an increment in the number of glomerular, tubu-
lar, and interstitial proliferating cells with respect to
sham-operated controls (Fig. 4). By light microscopy, mi-
totic figures were also observed within the tubular and
glomerular cells of spontaneously hypertensive rats +
subtotal nephrectomy (Fig. 5). Spontaneously hyperten-
sive rats + subtotal nephrectomy receiving quinapril,
losartan, or triple therapy showed less proliferating
glomerular, tubular, and infiltrating cells compared to
spontaneously hypertensive rats + subtotal nephrectomy
without treatment (Fig. 4).
Localization of apoptotic cells in renal tissue
Figure 6 shows photomicrographs of TUNEL immuno-
histochemistry of renal cortex from WKY and spon-
taneously hypertensive rats with and without subtotal
nephrectomy. Only very few cells were identified as apop-
totic in sham-operated WKY rats, spontaneously hy-
pertensive rats and WKY rats + subtotal nephrectomy.
However, in spontaneously hypertensive rats + subto-
tal nephrectomy many cells showing an intense brown
TUNEL-stained nuclei were observed in tubules (detail
in Fig. 7), interstitium, and vessels. In glomeruli, apoptotic
cells were seen, including epithelial cells from Bowman’s
capsule and podocytes (Figs. 6 and 8). The administration
of antihypertensive therapies to spontaneously hyperten-
sive rats + subtotal nephrectomy decreased significantly
the number of apoptotic cells, both in glomeruli and
tubulointerstitium, in comparison to nontreated spon-
taneously hypertensive rats + subtotal nephrectomy
(Fig. 6). Table 2 shows the localization of apoptotic cells
in the different groups. Interestingly, podocyte apopto-
sis was not detected in spontaneously hypertensive rats
+ subtotal nephrectomy treated with quinapril, losartan,
or triple therapy. These observations suggest that loss of
podocytes by apoptosis could be an important event in
the progression of glomerulosclerosis. Detailed studies
are ongoing in our laboratory to determine the molecu-
lar mechanisms implicated in this process.
Expression of apoptosis-related proteins
In comparison with sham-operated rats, both WKY +
subtotal nephrectomy and spontaneously hypertensive
rats + subtotal nephrectomy showed a significant incre-
ment in Bax levels in the renal cortex (Fig. 9A). However,
increased expression of Bcl-xL was noted in WKY rats +
subtotal nephrectomy with respect to WKY rats, but it
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Fig. 4. Localization of cell proliferation by proliferating cell nuclear
antigen (PCNA) immunolocalization in renal tissue from normal
Wistar-Kyoto (WKY) rats (A), WKY + subtotal nephrectomy (SNx)
(B), spontaneously hypertensive rats (SHR) (C), SHR + SNx (D),
quinapril (Q)-treated SHR + SNx (E), and triple therapy (TT)-treated
SHR + SNx (F). Many cells positive for PCNA were identified in
glomeruli and tubulointerstitium from WKY + SNx and SHR + SNx.
The administration of quinapril or triple therapy to SHR + SNx de-
creased significantly the number of proliferative cells in comparison
with nontreated SHR + SNx (magnification ×10). (G) Quantification
of PCNA-positive cells by image analysis. Data represent mean ± SEM,
N = 4 to 8 animals per group. ∗P < 0.05 with respect to the same
strain without SNx; #P < 0.05 with respect to SHR + SNx without
treatment.
Fig. 5. Mitotic cells (arrows) in glomeruli (g) and tubule (t) from a
representative spontaneously hypertensive rat + subtotal nephrectomy
(SHR + SNx). Some mitotic motifs showing signs of chromosome sep-
aration and chiasmata formation were detected in SHR + SNx (mag-
nification ×40).
was not significantly modified in spontaneously hyper-
tensive rats + subtotal nephrectomy compared to spon-
taneously hypertensive rats (Fig. 9B).
The administration of losartan, quinapril, or triple
therapy to spontaneously hypertensive rats + subtotal
nephrectomy reduced significantly Bax expression with
respect to spontaneously hypertensive rats + subtotal
nephrectomy without treatment (Fig. 9A). By contrast,
animals receiving losartan, quinapril, or triple therapy
did not show a significant modification in the Bcl-xL ex-
pression in renal cortex with respect to nontreated hy-
pertensive rats (Fig. 9B). In spontaneously hypertensive
rats + subtotal nephrectomy, these changes resulted in
an increased Bax/Bcl-xL ratio, an index of the suscepti-
bility of the cells to apoptosis. The Bax/Bcl-xL ratio was
decreased by the administration of the antihypertensive
treatments (Fig. 10).
Immunohistochemistry
Localization of Bax and Bcl-xL proteins is shown in
Figures 11 and 12. Both Bax and Bcl-xL immunostain-
ing was predominantly confined in proximal and distal
tubules and collecting ducts, and to a lesser extent in
glomeruli. In WKY rats and spontaneously hypertensive
rats without subtotal nephrectomy no positive immunos-
taining was detected. Confirming findings obtained with
Western blot, no differences were observed in Bax stain-
ing between WKY rats + subtotal nephrectomy and
spontaneously hypertensive rats + subtotal nephrectomy
animals (Fig. 11); however, Bcl-xL immunostaining was
decreased in spontaneously hypertensive rats + subtotal
nephrectomy in comparison with WKY rats + subtotal
nephrectomy rats (Fig. 12). Negative controls of the im-
munohistochemistry showing the specificity of the Bax
and Bcl-xL antibodies are shown in Figures11H and 12H,
respectively.
Semiquantification of Bax and Bcl-xL immunostaining
is shown in Table 3.
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Fig. 6. Localization of apoptotic cells in renal tissue from normal
Wistar-Kyoto (WKY) rats (A), WKY + subtotal nephrectomy (SNx)
(B), spontaneously hypertensive rats (SHR) (C), SHR + SNx (D),
quinapril (Q)-treated SHR + SNx (E), and triple therapy (TT)-treated
SHR + SNx (F). Few apoptotic cells were observed in glomeruli or
tubulointerstitium in WKY, WKY + SNx, and SHR. By contrast, many
apoptotic cells were observed in SHR + SNx. The administration of
quinapril or triple therapy to SHR + SNx rats decreased significantly
the number of apoptotic cells in comparison with nontreated SHR
+ SNx (magnification ×10). (G) Quantification of terminal deoxynu-
cleotidyl transferase (Tdt)-mediated deoxyuridine triphosphate biotin
nick end labeling (TUNEL)-positive cells by image analysis. Data repre-
sent mean ± SEM, N = 4 to 8 animals per group. ∗P < 0.05 with respect
to SHR; #P < 0.05 with respect to SHR + SNx without treatment.
Fig. 7. Detail of tubular nuclei that show intense brown terminal de-
oxynucleotidyl transferase (Tdt)-mediated deoxyuridine triphosphate
biotin nick end labeling (TUNEL) staining (arrows), in contrast to the
surrounding normal tubular nuclei (arrowhead), of a representative
spontaneously hypertensive rat + subtotal nephrectomy (SHR+SNx)
rat (magnification ×40).
Fig. 8. Detail of apoptotic cells in glomeruli from a representative
spontanteously hypertensive+subtotal nephrectomy (SHR+SNx) rat.
Some epithelial cells from Bowman’s capsule (arrows) and podocytes
(arrowhead) showed and intense terminal deoxynucleotidyl transferase
(Tdt)-mediated deoxyuridine triphosphate biotin nick end labeling
(TUNEL)-stained nuclei (magnification ×40).
DISCUSSION
Our results show that renal mass reduction led to more
severe renal lesions in spontaneously hypertensive rats
than in WKY rats and, indeed, to an increment in the
number of renal apoptotic cells in spontaneously hyper-
tensive rats + subtotal nephrectomy but not in WKY rats
+ subtotal nephrectomy. Tight control of blood pressure
with either an ACE inhibitor, an angiotensin II type 1 re-
ceptor (AT1) antagonist or triple-therapy was associated
with decreased proteinuria, renal lesions, cell turnover
and apoptosis rate.
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Table 2. Localization of terminal deoxynucleotidyl transferase
(Tdt)-mediated deoxyuridine triphosphate biotin nick end labeling
(TUNEL)-positive cells in normotensive Wistar-Kyoto (WKY) rats,
spontaneously hypertensive rats (SHR) with and without subtotal
nephrectomy (STNx). Some SHR with STNx received quinapril (Q)
(200 mg/L) or triple therapy (200 mg/L hydralazine, 4 mg/L reserpine,
100 mg/L hydrochlorothiazide) during 5 weeks
Tubular Vascular Interstitial
Glomeruli cells cells cells
WKY − − − −
WKY +STNx − −/+ − −/+
SHR − −/+ − −/+
SHR + STNx + +++ ++ ++
Q + SHR + STNx − + + −
TT + SHR + STNx − + + +
Nuclear DNA fragmentation was detected by TUNEL technique as described
in the Methods section. Data represent four to eight rats per group.
Early stages of renal injury involve compensatory re-
nal growth associated with hypertrophy and hyperplasia
[15]. By contrast, the late renal fibrotic stage is charac-
terized by the progressive loss of glomerular and tubular
cells, and their replacement by fibrous tissue, leading to
chronic tubulointerstitial injury and glomerular sclerosis
[16]. In general, proliferative and apoptotic changes take
place simultaneously, as a counterbalancing homeostatic
mechanism of cell number. It is well known that after in-
farction of 5/6 of the kidneys an increment in the prolifer-
ative processes and cellular hyperplasia is observed as an
adaptative response to the hemodynamic changes [17].
In our study, increased cell proliferation, not balanced by
increased apoptosis, was observed in WKY rats + subto-
tal nephrectomy. By contrast, increased cell turnover
(both increased proliferation and increased apoptosis)
was noted in spontaneously hypertensive rats with subto-
tal nephrectomy. It is known that the time necessary for a
complete proliferative cell cycle is around fivefold longer
than the apoptotic event [18, 19]. In addition Thomas
et al [20] demonstrated that some cells expressing PCNA
also stained positive by TUNEL, suggesting that the ex-
pression of PCNA may be a common cellular event in
proliferation and apoptosis. Therefore, in our study the
numerical match of the proliferative and apoptotic
changes would represent a predominance of the apop-
totic ones in spontaneously hypertensive rats with
subtotal nephrectomy, contributing to the loss of renal
parenchymal cells. Since both normotensive and hyper-
tensive animals have the same reduction of renal mass
and similar changes in renal cell proliferation, hyperten-
sion, or the genetic background could contribute to the
excess apoptosis observed in spontaneously hypertensive
rats + subtotal nephrectomy. In this regard, in target or-
gans of hypertension, mainly heart, kidney and brain,
apoptosis paralleling hypertrophy/hyperplasia has been
demonstrated, although a dissociation between both pro-
cesses has also been observed [21]. Hamet et al [21]
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Fig. 9. Bax (A) and Bcl-xL (B) protein expression in the renal cortex
from normal Wistar-Kyoto (WKY) rats, WKY + subtotal nephrectomy
(SNx), spontaneously hypertensive rats (SHR), SHR + SNx, quinapril
(Q)-treated SHR + SNx, losartan (L)-treated SHR + SNx, and triple
therapy (TT)-treated SHR + SNx. Upper panels, Western blot results
showing a representative animal from each group. Four to eight animals
per group were analyzed. Lower panels, Western blot densitometric re-
sults. Results are expressed as the fold-increase vs. sham-operated WKY
rats. Data represent mean ± SEM. ∗P < 0.05 vs. the same strain without
SNx; #P < 0.05 vs. SHR + SNx without treatment. AU is arbitrary units.
described an apoptotic window in the hearts of sponta-
neously hypertensive rats only during the development
(8 to 16 weeks) of hypertension that fell below the lev-
els observed in normotensive animals during established
hypertension (24 weeks of age).
We examined the effect of different antihypertensive
therapies on apoptosis in spontaneously hypertensive rats
+ subtotal nephrectomy. The administration of the ACE
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Fig. 10. Bax/Bcl-xL ratio in normal Wistar-Kyoto (WKY) rats, WKY
+subtotal nephrectomy (SNx), spontaneously hypertensive rats (SHR),
SHR + SNx, quinapril (Q)-treated SHR + SNx, losartan (L)-treated
SHR + SNx, and triple therapy (TT)-treated SHR + SNx. Data repre-
sent mean ± SEM, N = 4 to 8 animals per group. ∗P < 0.05 respect to the
same strain without SNx; #P < 0.05 vs. SHR + SNx without treatment.
inhibitor quinapril, the AT1 antagonist, losartan, or triple
therapy to spontaneously hypertensive rats with subto-
tal nephrectomy for 5 weeks normalized systolic blood
pressure, and reduced proteinuria, renal lesions and the
number of apoptotic cells. It is well known that the renin-
angiotensin system is activated in the remnant kidney
nephropathy[22]. Angiotensin II (Ang II), the main pep-
tide of the renin-angiotensin system, can act as a growth
factor, inducing, via a nonhemodynamic effect, cell pro-
liferation, hypertrophy, and expression of growth fac-
tors, through the activation of its AT1 receptors [23, 24].
Therefore, reduced apoptosis in response to antihyper-
tensive therapies may be, at least partially, a consequence
of reduced cellular proliferation. However, the role of the
renin-angiotensin system in apoptosis has been demon-
strated more directly by the finding that Ang II admin-
istration can induce apoptosis both in vivo and in vitro
[25–27]. Interestingly, Ang II induces apoptosis depend-
ing on the cell type and which receptor subtype is bound.
In vitro, it has been shown that the AT2 receptor exerts
apoptotic effects in different cells types, including tubular
epithelial cells [28, 29]. In vivo, we have recently demon-
strated that increased AT2 receptor-induced apoptosis
could be implicated in the renal lesions displayed by rats
with persistent proteinuria. However, AT1 receptors play
a more important proapoptotic role in cardiovascular cell
types, such as cardiomyocytes and vascular smooth mus-
cle cells [25, 30, 31]. More recently, it has been demon-
strated that Ang II induces an exaggerated apoptotic
response in cardiomyocytes from adult WKY rats [32].
Furthermore, whereas Ang II-induced apoptosis was pre-
vented by AT1 blockade in cardiomyocytes from adult
WKY normotensive rats, blockade of both the AT1 and
the AT2 receptor was needed to blunt the apoptotic re-
sponse to Ang II in SHR cardiomyocytes [32]. It has been
Fig. 11. Immunolocalization of Bax in the kidney from normal Wistar-
Kyoto (WKY) rats (A), WKY+ subtotal nephrectomy (SNx) (B), spon-
taneously hypertensive rats (SHR) (C), SHR + SNx (D), quinapril
(Q)-treated SHR + SNx (E), losartan (L)-treated SHR + SNx (F),
and triple therapy (TT)-treated SHR + SNx (G). A marked increase in
the intensity of the staining in proximal and distal tubules was observed
in WKY + SNx and SHR + SNx. (H) Renal sections incubated with
a non-immune normal rabbit serum instead of Bax antibody demon-
strates no immunostaining (magnification ×20).
proposed that Ang II-induced apoptosis depends on the
ratio between the expression of AT1 and AT2 receptors.
In this sense, we have observed that spontaneously hy-
pertensive rats with subtotal nephrectomy showed an in-
crement in the AT2 gene expression coinciding with the
enhanced number of apoptotic cells (unpublished data),
suggesting a potential mechanism by which Ang II could
induce apoptosis. Recently Miura and Karnik [33] have
proposed that AT2 receptor overexpression is a signal
for apoptosis, independently of Ang II binding. Further
studies are needed in order to assess the role of the Ang
II receptors in our model of subtotal nephrectomy.
A somewhat surprising result was the fact that, in our
model, triple therapy decreased PCNA- and TUNEL-
positive cells and Bax protein to a similar extent to that
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Fig. 12. Immunolocalization of Bcl-xL in the kidney from normal
Wistar-Kyoto (WKY) rats (A), WKY + subtotal nephrectomy (SNx)
(B), spontaneously hypertensive rats (SHR) (C), SHR + SNx (D),
quinapril (Q)-treated SHR + SNx (E), losartan (L)-treated SHR +
SNx (F), and triple therapy (TT)-treated SHR + SNx (G). A marked
increase in the intensity of the staining in proximal and distal tubules
was observed only in WKY + SNx. (H) Renal sections incubated with a
non-immune normal rabbit serum instead of Bcl-xS/L antibody demon-
strates no immunostaining (magnification ×20).
of quinapril and losartan, suggesting that the beneficial
effect of therapy depends on blood pressure control, at
least in the early stages of renal injury. Indeed, a similar
beneficial effect of triple therapy on this model had been
previously noted, although the influence on apoptosis was
not studied[10]. Tea et al [34] have reported that apop-
tosis is regulated in a time- and organ-specific manner
by cardiovascular drugs in vivo. Because we have inves-
tigated only one single time point, the effects of losartan,
quinapril, and triple therapy on renal apoptosis with an
earlier or more prolonged schedule of drug administra-
tion is unknown. In addition, an indirect effect of triple
therapy on renin-angiotensin system activation or effects
Table 3. Distribution of Bax and Bcl-xL staining is summarized
Bax Bcl-xL
Glomeruli Tubules Glomeruli Tubules
WKY − − − −
WKY + STNx − +++ −/+ +++
SHR − −/+ − −
SHR + STNx −/+ +++ − +
Q + SHR + STNx −/+ ++ − +
L + SHR + STNx −/+ ++ − +
TT + SHR + STNx −/+ ++ −/+ +
Data represent four to eight rats per group. Intensity was quantified as follows:
+, low; ++, medium; +++, high; −, absence of signal.
cannot be completely ruled out. Recently, it has been
reported that the administration of triple therapy signif-
icantly reduced tubular and interstitial PCNA staining
in unilateral ureteral obstruction, a hypertensive model
characterized by locally activated renin-angiotensin sys-
tem. Hydralazine, as part of the triple-therapy, may have
some antiproliferative properties in situations character-
ized by high Ang II both directly [26] or through the
inhibition of membrane-bound nicotinamide adenine
dinucleotide phosphate (NADH) oxidase, a key enzyme
in the Ang II-induced cell growth [35].
The molecular mechanisms of the increased apopto-
sis rate observed in spontaneously hypertensive rats with
subtotal nephrectomy are unknown. We have observed
an increment in the expression of the lethal protein Bax
in the renal cortex of all animals with subtotal nephrec-
tomy, which, as apoptosis, was mainly localized in tubular
epithelial cells. Bax was noted to be increased in WKY
rats with subtotal nephrectomy [36], as well as in other
models of renal damage (reviewed in [5]). An association
between increased apoptosis and overexpression of Bax
protein has also been reported in the left ventricle of adult
spontaneously hypertensive rats, which was normalized
with the administration of the AT1 receptor antagonist
losartan [31]. However, triple therapy was not studied by
these authors.
The balance between the pro- and antiapoptotic Bcl-
2 protein family members has been found to modulate
apoptosis in many systems. In our study, Bcl-xL protein
was increased in the renal cortex and tubular cells only in
normotensive WKY rats + subtotal nephrectomy, raising
a potential mechanism by which these animals could be
protected against apoptosis. Up-regulation of antiapop-
totic genes, such as Bcl-xL, in response to an adverse envi-
ronment, has been noted in other models of tubular injury
[37]. Interestingly, during nervous system ischemia failure
to up regulate Bcl-x was a feature of damaged neurons,
while it was increased in surviving neurons [38]. More
recently, we have demonstrated that Bcl-xL overexpres-
sion protects from apoptosis induced by statins in murine
tubular cells [39]. Strikingly, spontaneously hypertensive
rats + subtotal nephrectomy failed to up-regulate tubular
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Bcl-xL in response to renal mass reduction, leading to
an increased Bax/Bcl-xL ratio. Failure to up-regulate
Bcl-xL was associated with an enhanced apoptotic rate,
when compared to WKY rats + subtotal nephrectomy.
In a previous work, we have demonstrated that both
Bcl-2 and Bcl-xL proteins are significantly lower both
in glomeruli and mesangial cells in 8-week-old sponta-
neously hypertensive rats than in aged-matched WKY
rats [40]. In contrast, Bax proteins were significantly
higher in spontaneously hypertensive rats than in WKY
rats. In our study, the administration of three antihyper-
tensive therapies during 5 weeks to spontaneously hy-
pertensive rats at the age of 9 weeks did not modify the
Bcl-xL protein expression. Similarly, Liu et al [41] have
reported a cardiac decreased Bcl-2 expression, but a in-
creased Bax expression in spontaneously hypertensive
rats. However, the administration of the ACE inhibitor
ramipril to spontaneously hypertensive rats from 3 to
10 weeks of age resulted in a significant increase in Bcl-2
and a reduction in Bax. By contrast, Bcl-2 has been found
to have a similar expression in left ventricle from WKY
normotensive rats and spontaneously hypertensive rats
at 30 weeks of age [32]. In addition, the chronic admin-
istration of losartan decreased Bax expression but did
not modify the amount of Bcl-2 in the ventricles of spon-
taneously hypertensive rats. Thus, taken together, these
data strongly suggest that apoptosis is regulated in a time-
and organ-specific manner by antihypertensive drugs in
vivo.
One major finding of our study was that blood pressure
control did not result in increased anti-apoptosis Bcl-xL
protein expression. This suggests that suppressed expres-
sion in Bcl-xL in spontaneously hypertensive rats could
be independent of hypertension and subtotal nephrec-
tomy and related to the genetic background. The cell sig-
nals that regulate Bcl-xL expression are unclear, although
several transcription factors, including nuclear factor-jB
(NF-jB), have recently been reported to directly regulate
the Bcl-x gene [42]. Inhibition of NF-jB reduces Bcl-
xL expression and sensitizes cells to TRAIL or [tumor
necrosis factor-a (TNFa)]-induced apoptosis in different
cell types [43, 44]. In vitro studies from our laboratory
have demonstrated that mesangial cells obtained from
hypertensive rats are more susceptible to TNF-a–induced
apoptosis and they have less NF-jB activity than those
obtained from normotensive rats [40]. Research currently
under way in our laboratory is aimed at amplifying these
findings and trying to solve the mechanisms responsible.
Our results, together with others in the literature, sug-
gest that accelerated or excess apoptosis could contribute
to the severity of renal lesions displayed by hypertensive,
but not by normotensive rats, after subtotal nephrec-
tomy. In this sense, at 5 weeks, spontaneously hyperten-
sive rats with subtotal nephrectomy showed similar renal
lesions to those found in normotensive rats with subto-
tal nephrectomy at day 90 in a previous paper [20]. In
summary, at the time studied, subtotal nephrectomy in-
duces in spontaneously hypertensive rats a greater ac-
tivation of apoptotic mechanisms that could contribute
to the earlier severity of renal damage observed in this
model. Tight control of systolic blood pressure by ei-
ther the administration of an AT1 receptor antagonist,
an ACE inhibitor, or triple therapy was associated to the
improvement of histologic lesions and the decrease in
the apoptotic rate. Finally, our data suggest differences
in the molecular mechanisms that control apoptotic cell
death in hypertensive rats in comparison with normoten-
sive rats.
ACKNOWLEDGMENTS
This work has been supported partially by grants from European
Grant of Shared-cost RTD actions (QLG1-2002-1215), Comunidad
de Madrid (08.4/0021/2003, 08.2/0030/2000), Fondo de Investigacio´n
Sanitaria (FIS) (01/3151 and 01/0199), Ministerio de Ciencia y Tec-
nologı´a (SAF 2001/0717), Instituto de Investigaciones Nefrolo´gicas
“Reina Sofı´a,” and Fundacio´n In˜igo A´lvarez de Toledo. R.L., J.G.-D.,
and M.P.C. are fellows from CAM, FIS and MEC respectively.
Reprint requests to Dulcenombre Go´mez-Garre, Ph.D., Laboratorio
de Biologı´a Vascular y Arteriosclerosis, Medicina Interna III (secretarı´a),
4aplanta sur, Hospital Clı´nico San Carlos, C/Martı´n Lagos s/n, 28040-
Madrid, Spain.
Email: mgomezg.hcsc@salud.madrid.org
REFERENCES
1. USRDS: United States Renal Data System 1995 Annual Data Re-
port: Incidence and causes of treated end-stage renal disease. Am J
Kidney Dis 26(Suppl 2):S39–S50, 1995
2. RIAO N, LUN˜O J, GARCı´A DE VINUESA S, et al: Prevalence of hyper-
tension in renal disease. Nephrol Dial Transplant 16(Suppl 1):70–73,
2001
3. MARIN R, GOROSTIDI M, POBES A: Arterial hypertension and renal
vascular disease: Nephroangiosclerosis. Nefrologı´a 22(Suppl 1):36–
45, 2002
4. ORTIZ A, LORZ C, JUSTO P, et al: Contribution of apoptotic cell death
to renal injury. J Cell Mol Med 5:18–32, 2001
5. ORTIZ A, LORZ C, CATALA´N MP, et al: Role and regulation of apop-
totic cell death in the kidney. Y2K update. Front Biosci 5:D735–
D749, 2000 (http://www.bioscience.org/2000/v5/d/ortiz/fulltext.htm)
6. YING W-Z, WANG P-X, SANDERS PW: Induction of apoptosis during
development of hypertensive nephrosclerosis. Kidney Int 58:2007–
2017, 2000
7. REED J: Bcl-2 family proteins: Strategies for overcoming chemore-
sistance in cancer. Adv Pharmacol 41:501–532, 1997
8. SEDLAK TW, OLTVAI ZN, YANG E, et al: Multiple Bcl-2 family mem-
bers demonstrate selective dimerizations with Bax. Proc Natl Acad
Sci USA 92:834–838, 1995
9. GONZA´LEZ-GARCı´A M, PE´REZ-BALLESTERO R, DING L, et al: Bcl-XL is
the major Bcl-x mRNA form expressed during murine development
and its product localizes to mitochondria. Development 120:3033–
3042, 1994
10. BIDANI AK, GRIFFIN KA, PLOTT W, SHWARTZ MM: Renal ab-
lation acutely transforms “benign” hypertension to “malignant”
nephrosclerosis in hypertensive rats. Hypertension 24:309–316,
1994
11. GYURE WL: Comparison of several methods for semiquantitative
determination of urinary protein. Clin Chem 23:876–879, 1977
12. SUGIYAMA H, KASHIHARA N, MAKINO H, et al: Apoptosis in glomeru-
lar sclerosis. Kidney Int 49:103–111, 1996
822 Soto and Go´mez-Garre et al: Renal apoptosis and hypertension
13. GO´MEZ-GARRE D, LARGO R, TEJERA N, et al: Activation of NF-jB
in tubular epithelial cells of rats with intense proteinuria. Role of
angiotensin II and endothelin-1. Hypertension 37:1171–1178, 2001
14. MOREAU P, TEA BS, DAM TV, HAMET P: Altered balance between
cell replication and apoptosis in hearts and kidneys of newborn
SHR. Hypertension 30:720–724, 1997
15. WESSON LG: Compensatory renal growth and other growth re-
sponses of kidney. Nephron 51:149–184, 1989
16. KLAHR S: Progression of chronic renal disease. Heart Dis 3:205–209,
2001
17. KLIEM V, JOHNSON RJ, ALPERS CE, et al: Mechanisms involved in
the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized
rats. Kidney Int 49:666–678, 1996
18. ARENDS MJ, WYLLIE AH: Apoptosis. Mechanisms and role in pathol-
ogy. Int Rev Exp Pathol 32:223–254, 1991
19. BRAVO R, MACDONALD-BRAVO H: Existence of two populations of
cyclin/proliferating cell nuclear antigen during the cell cycle: Asso-
ciation with DNA replication sites. J Cell Biol 105:1549–1554, 1987
20. THOMAS GL, YANG B, WAGNER BE, et al: Cellular apoptosis and
proliferation in experimental renal fibrosis. Nephrol Dial Transplant
13:2216–2226, 1998
21. HAMET P, MOREAU P, DAM TV, et al: The time window of apoptosis:
A new component in the therapeutic strategy for cardiovascular
remodeling. J Hypertens 14:S65–S70, 1996
22. OTS M, MACKENZIE HS, TROY JL, et al: Effects of combination ther-
apy with enalapril and losartan on the rate of progression of renal
injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 9:224–
230, 1998
23. GO´MEZ-GARRE D, RUIZ-ORTEGA M, ORTEGO M, et al: Effects and
interactions of endothelin-1 and angiotensin II on matrix protein
expression and synthesis and mesangial cell growth. Hypertension
27:885–892, 1996
24. MEZZANO SA, RUIZ-ORTEGA M, EGIDO J: Angiotensin II and renal
fibrosis. Hypertension 38:635–638, 2001
25. DIEP QN, LI J-S, SCHIFFRIN EL: In vivo study of AT1 and AT2 an-
giotensin receptors in apoptosis in rat blood vessels. Hypertension
34:617–624, 1999
26. AIZAWA T, ISHIZAKA N, KUROKAWA K, et al: Different effects of
angiotensin II and catecholamine on renal cell apoptosis and pro-
liferation in rats. Kidney Int 59:645–653, 2001
27. DIMMELER S, RIPPMANN V, WEILAND U, et al: Angiotensin II induces
apoptosis of human endotelial cells. Protective effect of nitric oxide.
Circ Res 81:970–976, 1997
28. DE GASPARO M, SIRAGY HM: The AT2 receptor: Fact, fancy and
fantasy. Regulatory Peptides 81:11–24, 1999
29. ZIMPELMANN J, BURNS KD: Angiotensin II AT2 receptors inhibit
growth responses in proximal tubule cells. Am J Physiol Renal
281:F300–F308, 2001
30. KAJSTURA J, CIGOLA E, MALHOTRA A, et al: Angiotensin II induces
apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol
29:859–870, 1997
31. FORTUN˜O MA, RAVASSA S, ETAYO JC, Dı´EZ J: Overexpression of
Bax protein and enhanced apoptosis in the left ventricle of sponta-
neously hypertensive rats: Effects of AT1 blockade with losartan.
Hypertension 32:280–286, 1998
32. RAVASSA S, FORTUN˜O MA, GONZA´LEZ A, et al: Mechanisms of in-
creased susceptibility to angiotensin II-induced apoptosis in ven-
tricular cardiomyocytes of spontaneously hypertensive rats. Hyper-
tension 36:1065–1071, 2000
33. MIURA S, KARNIK SS: Ligand-independent signals from angiotensin
II type 2 receptor induce apoptosis. EMBO J 19:4026–4035, 2000
34. TEA B-S, DAM T-V, MOREAU P, et al: Apoptosis during regression
of cardiac hypertrophy in spontaneously hypertensive rats. Tempo-
ral regulation and spatial heterogeneity. Hypertension 34:229–235,
1999
35. MUNZEL T, KURZ S, RAJAGOPALAN S, et al: Hydralazine prevents ni-
troglycerin tolerance by inhibiting activation of a membrane-bound
NADH oxidase. A new action for an old drug. J Clin Invest 98:1465–
1470, 1996
36. YANG B, JOHNSON TS, THOMAS GL, et al: Expression of apoptosis-
related genes and proteins in experimental chronic renal scarring.
J Am Soc Nephrol 12:275–288, 2001
37. ORTIZ A, LORZ C, CATALA´N MP, et al: Expression of apoptosis regu-
latory proteins in tubular epithelium stressed in culture or following
acute renal failure. Kidney Int 57:969–981, 2000
38. ISENMANN S, STOLL G, SCHROETER M, et al: Differential regulation of
Bax, Bcl-2, and Bcl-X proteins in focal cortical ischemia in the rat.
Brain Pathol 8:49–62, 1998
39. BLANCO-COLIO LM, JUSTO P, DAEHN I, et al: Bcl-xL overexpression
protects from apoptosis induced by HMG-CoA reductase inhibitors
in murine tubular cells. Kidney Int 64:181–191, 2003
40. GO´MEZ-GARRE D, SOTO K, LARGO R, et al: Papel del NF-jB en la
susceptibilidad a la apoptosis mostrada por las ce´lulas mesangiales
de ratas esponta´neamente hipertensas. Investigacio´n Cardiovascu-
lar 6:54–70, 2003
41. LIU JJ, PENG L, BRADLEY CJ, et al: Increased apoptosis in the heart
of genetic hypertension, associated with increased fibroblasts. Car-
diovasc Res 45:729–735, 2000
42. GRAD JM, ZENG XR, BOISE LH: Regulation of Bcl-xL: A little bit
of this and a little bit of STAT. Curr Opin Oncol 12:543–549, 2000
43. MUKHOPADHYAY A, BUESO-RAMOS C, CHATTERJEE D, et al: Curcumin
downregulates cell survival mechanisms in human prostate cancer
cell lines. Oncogene 20:7597–7609, 2001
44. RAVI R, BEDI GC, ENGSTROM LW, et al: Regulation of death receptor
expression and TRAIL/Apo2L-induced apoptosis by NF-jB. Nat
Cell Biol 3:409–416, 2001
